Chris’ background is in finance and broking. His role is maintaining and strengthening RAC’s relationships with brokers and investors. Bridging the understanding gap between the scientists and brokers is not an easy job and it is one that many small ASX listed biotechs get wrong.
RAC
race oncology ltd
Add to My Watchlist
3.38%
!
$1.15

Responsibilities of the team, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.15 |
Change
-0.040(3.38%) |
Mkt cap ! $200.6M |
Open | High | Low | Value | Volume |
$1.22 | $1.22 | $1.13 | $117.1K | 101.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 359 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 17579 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2932 | 1.140 |
3 | 5274 | 1.135 |
5 | 7762 | 1.130 |
1 | 2008 | 1.125 |
5 | 14965 | 1.120 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 16714 | 2 |
1.205 | 2500 | 1 |
1.220 | 21445 | 4 |
1.230 | 7500 | 2 |
1.245 | 2000 | 1 |
Last trade - 15.06pm 04/07/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online